Ibacitabine (or ibacitabin,[1] or 5-iodo-2'-deoxycytidine ) is an antiviral drug. It is topically applied to treat herpes labialis.[2]
Names | |
---|---|
IUPAC name
2′-Deoxy-5-iodocytidine
| |
Systematic IUPAC name
4-Amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2(1H)-one | |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.009.337 |
KEGG | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C9H12IN3O4 | |
Molar mass | 353.11375 |
Pharmacology | |
D06BB08 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
References
edit- ^ Serpentier-Daude, A.; Collet, E.; Didier, A. F.; Touraud, J. P.; Sgro, C.; Lambert, D. (February 2000). "[Contact dermatitis to topical antiviral drugs]". Ann Dermatol Venereol. 127 (2): 191–3. PMID 10739980.
- ^ Groot, Anton C. de (2021). Topical drugs (First ed.). Boca Raton, FL: CRC Press. p. 421. ISBN 9781000367867.
External links
edit